tradingkey.logo

tradingkey.logo
怜玢


Calidi Biotherapeutics Inc

CLDI
りォッチリストに远加
0.622USD
-0.033-5.04%
終倀 11-13 16:00ET
2.29M時䟡総額
損倱額盎近12ヶ月PER
時間倖取匕 18:30 (ET)0.622USD0.000

Calidi Biotherapeutics Incに぀いお 䌁業名

Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company. The Company is developing proprietary allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses (vaccinia virus and adenovirus) and, potentially, other molecules to cancer patients. It is focused on developing two proprietary stem cell-based platforms and one enveloped vaccinia virus platform designed to protect the oncolytic virus, whether natural or engineered, from neutralization by the patient’s immune defenses, allowing for greater infection of the tumor cells and leading to a potential improvement in the antitumor activity of oncolytic viruses over traditional naked oncolytic virus therapies. Its product candidates include the CLD-101 product for high grade glioma (HGG), CLD-101 product for Recurrent HGG, CLD-201 product for solid tumors, CLD-301 (AAA) for multiple indications and CLD-400 (RTNova) for certain lung cancer and metastatic solid tumors.

Calidi Biotherapeutics Inc プロフィヌル


䌁業コヌドCLDI
䌚瀟名Calidi Biotherapeutics Inc
䞊堎日Sep 10, 2021
最高経営責任者「CEO」Poma (Eric)
埓業員数28
蚌刞皮類Ordinary Share
決算期末Sep 10
本瀟所圚地4475 Executive Drive, Suite 200
郜垂SAN DIEGO
蚌刞取匕所NASDAQ OMX – NASDAQ Basic Amex
囜United States of America
郵䟿番号92121
電話番号18587949600
りェブサむトhttps://www.calidibio.com/
䌁業コヌドCLDI
䞊堎日Sep 10, 2021
最高経営責任者「CEO」Poma (Eric)

Calidi Biotherapeutics Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Scott Leftwich
Mr. Scott Leftwich
Independent Director
Independent Director
9.16K
--
Mr. James A. Schoeneck
Mr. James A. Schoeneck
Independent Chairman of the Board
Independent Chairman of the Board
5.28K
--
Mr. Andrew C. Jackson
Mr. Andrew C. Jackson
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
156.00
--
Mr. Alan R. Stewart
Mr. Alan R. Stewart
Independent Director
Independent Director
151.00
--
Mr. Allan J. Camaisa
Mr. Allan J. Camaisa
Independent Director
Independent Director
--
--
Col. (Retd.) George E. Peoples, Jr., M.D.
Col. (Retd.) George E. Peoples, Jr., M.D.
Independent Director
Independent Director
--
--
Dr. Travis Clifton, M.D.
Dr. Travis Clifton, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Eric Poma, Ph.D.
Dr. Eric Poma, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Corazon Dating (Corsee) Sanders, Ph.D.
Dr. Corazon Dating (Corsee) Sanders, Ph.D.
Independent Director
Independent Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Scott Leftwich
Mr. Scott Leftwich
Independent Director
Independent Director
9.16K
--
Mr. James A. Schoeneck
Mr. James A. Schoeneck
Independent Chairman of the Board
Independent Chairman of the Board
5.28K
--
Mr. Andrew C. Jackson
Mr. Andrew C. Jackson
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
156.00
--
Mr. Alan R. Stewart
Mr. Alan R. Stewart
Independent Director
Independent Director
151.00
--
Mr. Allan J. Camaisa
Mr. Allan J. Camaisa
Independent Director
Independent Director
--
--
Col. (Retd.) George E. Peoples, Jr., M.D.
Col. (Retd.) George E. Peoples, Jr., M.D.
Independent Director
Independent Director
--
--

よくある質問

Calidi Biotherapeutics Incの䞊䜍5名の株䞻は誰ですか


Calidi Biotherapeutics Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Scott Leftwich

Calidi Biotherapeutics IncCLDIの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Calidi Biotherapeutics Incの株匏を保有しおいる機関は70瀟あり、保有株匏の総垂堎䟡倀は玄712.13Kで、党䜓の4.68%を占めおいたす。2025Q4ず比范しお、機関の持ち株は324855.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。